HB2402Introduced in the House
Concerning phthalates in medical equipment used for intravenous purposes.
Introduced by Monica Stonier, District 049B
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Concerning phthalates in medical equipment used for intravenous purposes.
Where it stands
Referred to Rules 2 Review.
February 4, 2026
How did lawmakers vote?
HouseStage: House Committee on Health Care & Wellness: 1st substitute bill be substituted, do pass · February 4, 2026
12
Yes
0
No
5
Absent or Not Voting
17 representatives recorded in this House vote. Colors show vote categories only, not whether a vote was good or bad.
See how each representative voted
| Representative | District | Vote |
|---|---|---|
| Matt Marshall | 002B | Not Voting |
| Andrew Engell | 007A | Not Voting |
| Joe Schmick | 009B | Not Voting |
| Clyde Shavers | 010A | Yes |
| Deb Manjarrez | 014B | Not Voting |
| David Stuebe | 017B | Yes |
| Lisa Parshley | 022B | Yes |
| Michelle Valdez | 026B | Yes |
| Dan Bronoske | 028B | Yes |
| Lauren Davis | 032B | Yes |
Bill history
First reading, referred to Environment & Energy.
Committee relieved of further consideration.
Referred to Health Care & Wellness.
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
HCW - Majority; 1st substitute bill be substituted, do pass.
Minority; without recommendation.
Referred to Rules 2 Review.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.